Civil cover sheets need not be filed for cases directly filed in the Sep 23, 2014 · As discovery continues in the federal Lipitor litigation involving lawsuits brought by women who allege the popular cholesterol drug caused them to develop type II diabetes, the U
Peggy’s Lipitor lawsuit is part of the multidistrict litigation, or MDL This multidistrict litigation currently consists of over two thousand cases pending before
M
The $93 million settlement announced on February 7 will be paid to direct
This trial provides evidence that the use of intensive atorvastatin therapy
Pfizer's Lipitor is a cholesterol-lowering drug facing litigation over the risk of Type-2
District Judge Richard Gergel of Charleston
20 suggested that nine Lipitor diabetes cases be remanded to California state court, saying the plaintiffs have a colorable claim against the California distributor (In Re: Lipitor [Atorvastatin Calcium] Marketing, Sales Practices and Products Liability Litigation, MDL Docket No
K
The U
2502; In Re: Lipitor (Atorvastatin Calcium) Marketing, Sales Practices A total of 10,001 patients with clinically evident CHD and LDL cholesterol levels of less than 130 mg per deciliter (3
The Lipitor MDL contains more than 1,300 lawsuits alleging the statin drug caused plaintiffs to develop type-2 diabetes
The end-payors in the multidistrict litigation accuse Pfizer of giving Ranbaxy the right to sell generic versions of Lipitor abroad in exchange for Ranbaxy pulling a patent challenge that could Any plaintiff whose case would be subject to transfer the Lipitor MDL proceedings may file his or her case directly in the District of South Carolina, in accordance with Paragraphs 17-21 of CMO 4
MULTIDISTRICT LITIGATION IN RE: LIPITOR (ATORVASTATIN CALCIUM) MARKETING, SALESPRACTICES AND PRODUCTS LIABILITY LITIGATION (NO
§ 1407, plaintiff in an action (Christopher) pending in the Middle District of Louisiana moves to centralize
); IN RE: Actos (Pioglitazone) Products Liability Litigation, MDL 2299 (W
N
§ 1407 Water contamination at Camp Lejeune in North Carolina between 1953 and 1987 caused cancers, birth defects, miscarriages and other side effects for U
At the time it was developed, it fell under the Parke-Davis Company, which was acquired by Warner-Lambert and then Pfizer
Paul Tassin | May 8, 2015 Category: Legal News
Dozens of plaintiffs across the United States have filed injury lawsuits against the manufacturer, alleging that
Case Management Order 08/10/12